Evaluation of Interleukin 6 as a predictor biomarker of advanced liver fibrosis in chronic hepatitis C patients
Microbes and Infectious Diseases · 14.03.2026 · 0-0
DOI: 10.21608/mid.2026.458652.3631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbes and Infectious Diseases, online erschienen am 14.03.2026. Verfasst von Hamdy H Omar und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Omar, H. H., Soliman, M. H., Omar, H. H., Fouad, M. M., Omar, W. H., Abdalla, M. H., & Nassar, H. A. (2026). Evaluation of Interleukin 6 as a predictor biomarker of advanced liver fibrosis in chronic hepatitis C patients. Microbes and Infectious Diseases, 0(0), 0-0. https://doi.org/10.21608/mid.2026.458652.3631
Vancouver
Omar HH, Soliman MH, Omar HH, Fouad MM, Omar WH, Abdalla MH, et al. Evaluation of Interleukin 6 as a predictor biomarker of advanced liver fibrosis in chronic hepatitis C patients. Microbes and Infectious Diseases. 2026;0(0):0-0. doi:10.21608/mid.2026.458652.3631
BibTeX
@article{Omar2026,
author = {Omar, Hamdy H and Soliman, Mohamed H and Omar, Hanan H and Fouad, Marwa Mohamed and Omar, Wafaa Hassan and Abdalla, Mohamed H and Nassar, Hasnaa A},
title = {Evaluation of Interleukin 6 as a predictor biomarker of advanced liver fibrosis in chronic hepatitis C patients},
journal = {Microbes and Infectious Diseases},
year = {2026},
volume = {0},
number = {0},
pages = {0--0},
doi = {10.21608/mid.2026.458652.3631}
}
EUVIMED